Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence

Published:2024 Issue: Volume:39 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Hwang Hun-Gyu¹^ORCID,Lee Ju Hyun²^ORCID,Kim Sang-A²^ORCID,Kim Yang-Ki³^ORCID,Kim Myung-Shin¹^ORCID,Hong Junshik⁴^ORCID,Yhim Ho-Young⁵^ORCID,Bang Soo-Mee²^ORCID

Affiliation:

1. Respiratory Division, Department of Internal Medicine, Soonchunhyang University Gumi Hospital, Soonchunhyang University School of Medicine, Gumi, Korea.

2. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.

3. Respiratory Division, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University School of Medicine, Seoul, Korea.

4. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

5. Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.

Funder

Korean Society on Thrombosis and Hemostasis

Soonchunhyang University

Publisher

XMLink

Link

https://jkms.org/pdf/10.3346/jkms.2024.39.e252

Reference23 articles.

1. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

2. Single or triple positivity for antiphospholipid antibodies in “carriers” or symptomatic patients: Untangling the knot

3. Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome

4. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity

5. Epidemiology of the Antiphospholipid Antibody Syndrome